Lewy Body Dementia Association’s Research Centers of Excellence Program: Inaugural Meeting Proceedings

The first Lewy Body Dementia Association (LBDA) Research Centers of Excellence (RCOE) Investigator’s meeting was held on December 14, 2017, in New Orleans. The program was established to increase patient access to clinical experts on Lewy body dementia (LBD), which includes dementia with Lewy bodies...

Descripción completa

Detalles Bibliográficos
Autores principales: Peterson, Bethany, Armstrong, Melissa, Galasko, Douglas, Galvin, James E., Goldman, Jennifer, Irwin, David, Paulson, Henry, Kaufer, Daniel, Leverenz, James, Lunde, Angela, McKeith, Ian G., Siderowf, Andrew, Taylor, Angela, Amodeo, Katherine, Barrett, Matt, Domoto-Reilly, Kimiko, Duda, John, Gomperts, Stephen, Graff-Radford, Neill, Holden, Samantha, Honig, Lawrence, Huddleston, Daniel, Lippa, Carol, Litvan, Irene, Manning, Carol, Marder, Karen, Moussa, Charbel, Onyike, Chiadi, Pagan, Fernando, Pantelyat, Alexander, Pelak, Victoria, Poston, Kathleen, Quinn, Joseph, Richard, Irene, Rosenthal, Liana S., Sabbagh, Marwan, Scharre, Douglas, Sha, Sharon, Shill, Holly, Torres-Yaghi, Yasar, Christie, Tina, Graham, Todd, Richards, Ian, Koehler, Mike, Boeve, Brad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Meeting Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417280/
https://www.ncbi.nlm.nih.gov/pubmed/30867052
http://dx.doi.org/10.1186/s13195-019-0476-1
Descripción
Sumario:The first Lewy Body Dementia Association (LBDA) Research Centers of Excellence (RCOE) Investigator’s meeting was held on December 14, 2017, in New Orleans. The program was established to increase patient access to clinical experts on Lewy body dementia (LBD), which includes dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD), and to create a clinical trials-ready network. Four working groups (WG) were created to pursue the LBDA RCOE aims: (1) increase access to high-quality clinical care, (2) increase access to support for people living with LBD and their caregivers, (3) increase knowledge of LBD among medical and allied (or other) professionals, and (4) create infrastructure for a clinical trials-ready network as well as resources to advance the study of new therapeutics.

Ejemplares similares